These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 32939018

  • 1. Sequence specificity analysis of the SETD2 protein lysine methyltransferase and discovery of a SETD2 super-substrate.
    Schuhmacher MK, Beldar S, Khella MS, Bröhm A, Ludwig J, Tempel W, Weirich S, Min J, Jeltsch A.
    Commun Biol; 2020 Sep 16; 3(1):511. PubMed ID: 32939018
    [Abstract] [Full Text] [Related]

  • 2. Kinetic characterization of human histone H3 lysine 36 methyltransferases, ASH1L and SETD2.
    Eram MS, Kuznetsova E, Li F, Lima-Fernandes E, Kennedy S, Chau I, Arrowsmith CH, Schapira M, Vedadi M.
    Biochim Biophys Acta; 2015 Sep 16; 1850(9):1842-8. PubMed ID: 26002201
    [Abstract] [Full Text] [Related]

  • 3. Structural and enzymatic evidence for the methylation of the ACK1 tyrosine kinase by the histone lysine methyltransferase SETD2.
    Le Coadou L, Berthelet J, Mechaly AE, Michail C, Bui LC, Dairou J, Haouz A, Dupret JM, Rodrigues Lima F.
    Biochem Biophys Res Commun; 2024 Feb 05; 695():149400. PubMed ID: 38160530
    [Abstract] [Full Text] [Related]

  • 4. Discovery of NSD2 non-histone substrates and design of a super-substrate.
    Weirich S, Kusevic D, Schnee P, Reiter J, Pleiss J, Jeltsch A.
    Commun Biol; 2024 Jun 08; 7(1):707. PubMed ID: 38851815
    [Abstract] [Full Text] [Related]

  • 5. The lysine methyltransferase SETD2 is a dynamically expressed regulator of early neural crest development.
    Roffers-Agarwal J, Lidberg KA, Gammill LS.
    Genesis; 2021 Oct 08; 59(10):e23448. PubMed ID: 34498354
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis.
    Martinelli G, Mancini M, De Benedittis C, Rondoni M, Papayannidis C, Manfrini M, Meggendorfer M, Calogero R, Guadagnuolo V, Fontana MC, Bavaro L, Padella A, Zago E, Pagano L, Zanotti R, Scaffidi L, Specchia G, Albano F, Merante S, Elena C, Savini P, Gangemi D, Tosi P, Ciceri F, Poletti G, Riccioni L, Morigi F, Delledonne M, Haferlach T, Cavo M, Valent P, Soverini S.
    Leukemia; 2018 Jan 08; 32(1):139-148. PubMed ID: 28663576
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas.
    Fontebasso AM, Schwartzentruber J, Khuong-Quang DA, Liu XY, Sturm D, Korshunov A, Jones DT, Witt H, Kool M, Albrecht S, Fleming A, Hadjadj D, Busche S, Lepage P, Montpetit A, Staffa A, Gerges N, Zakrzewska M, Zakrzewski K, Liberski PP, Hauser P, Garami M, Klekner A, Bognar L, Zadeh G, Faury D, Pfister SM, Jabado N, Majewski J.
    Acta Neuropathol; 2013 May 08; 125(5):659-69. PubMed ID: 23417712
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The Benzene Hematotoxic and Reactive Metabolite 1,4-Benzoquinone Impairs the Activity of the Histone Methyltransferase SET Domain Containing 2 (SETD2) and Causes Aberrant Histone H3 Lysine 36 Trimethylation (H3K36me3).
    Berthelet J, Michail C, Bui LC, Le Coadou L, Sirri V, Wang L, Dulphy N, Dupret JM, Chomienne C, Guidez F, Rodrigues-Lima F.
    Mol Pharmacol; 2021 Sep 08; 100(3):283-294. PubMed ID: 34266924
    [Abstract] [Full Text] [Related]

  • 14. Identification of nonhistone substrates of the lysine methyltransferase PRDM9.
    Hanquier JN, Sanders K, Berryhill CA, Sahoo FK, Hudmon A, Vilseck JZ, Cornett EM.
    J Biol Chem; 2023 May 08; 299(5):104651. PubMed ID: 36972790
    [Abstract] [Full Text] [Related]

  • 15. Activity and specificity of the human SUV39H2 protein lysine methyltransferase.
    Schuhmacher MK, Kudithipudi S, Kusevic D, Weirich S, Jeltsch A.
    Biochim Biophys Acta; 2015 Jan 08; 1849(1):55-63. PubMed ID: 25459750
    [Abstract] [Full Text] [Related]

  • 16. Catalytic properties and kinetic mechanism of human recombinant Lys-9 histone H3 methyltransferase SUV39H1: participation of the chromodomain in enzymatic catalysis.
    Chin HG, Patnaik D, Estève PO, Jacobsen SE, Pradhan S.
    Biochemistry; 2006 Mar 14; 45(10):3272-84. PubMed ID: 16519522
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.